Once-daily treatment for canine atopic dermatitis
Delivers 6-in-1 parasite protection for cats
Valuable discounts, expert information, and tips
See how injectable medications offer value beyond the prescription
The first and only FDA-Approved veterinary antiemetic
The first long-lasting monoclonal antibody therapy for canine atopic dermatitis
Vaccination for the prevention of respiratory disease caused by BRSV
The beef industry’s No. 1 branded preconditioning program
Exclusive pricing program for Cattle producers
Outstanding protection against costly respiratory and reproductive diseases
Treatment and control of gastrointestinal roundworms, lungworms, eyeworms, grubs, sucking lice and mange mites
Innovative food safety products that help deliver a farm-to-fork solution for beef
The most comprehensive guarantee available
First and only FDA-approved antibiotic for horses that offers a full course of therapy in just two doses
Annual vaccination with CORE EQ INNOVATOR helps provide the protection your horse needs
Treats and controls encysted small strongyles, bots and roundworms. QUEST PLUS contains an additional active ingredient for efficacy against tapeworms
Patented and scientific method of determining fair service pricing to improve your clinic's profitability
Connect directly to valuable dairy management resources and experts
The most "veterinarian recommended" and "producer used" prostaglandin in the market
Delivers the peace of mind and profitability that come with no milk discard
Effective and convenient treatment for acute metritis in cattle
Working together to improve reproduction
One injection treats and controls swine respiratory disease for 7 days
Protect sows and gilts from costly breeding herd diseases — parvovirus, leptospirosis and erysipelas
The industry standard for in ovo technology.
Full automation solutions for hatchery automation
Prevention and control of necrotic enteritis, increased rate of weight gain and improved feed efficiency in poultry
for the prevention of coccidiosis in poultry
modified-live vaccine that helps poultry companies reduce their overall Salmonella load
Blood glucose monitoring system
Smart new diagnostics platform that can reinvent your in-house diagnostic routines
Detect Johne’s Disease with confidence in cattle and goat herds
Simple and effective detection of a deadly Feline Virus
Accurate, affordable and easy to use
Order Beef Genetics products online
Order Dairy Genetics products online
Delivers reliable predictions of genetic merit based on test results of core traits
Represents the latest advancement in Angus genotyping technology.
Register today to learn more
Become a more effective leader
Looking for a tailored experience?
Earn continuing education credits and stay current on industry developments with Zoetis’ convenient, on-demand learning solutions.
Veterinarians, Veterinarian Techs, Business Owners, and Farm Hands
Launch your veterinary career
Veterinarian Students and Recent Graduates
Animal health expertise and results-focused resources for high-performing teams and leaders.
Veterinarians, Dairy producers, Beef producers, Equine Specialists, Pork producers, Poultry producers, Managers, Business Owners and Staff
Home / NEWS & MEDIA / Zoetis Introduces First Licensed Equine Leptospirosis Vaccine
New LEPTO EQ INNOVATOR® helps protect horses from leptospirosis caused by L. pomona.
FLORHAM PARK, N.J., Nov. 10, 2015 — Today Zoetis announced the introduction of LEPTO EQ INNOVATOR®, the first and only vaccine licensed for use in horses, six months of age or older, to aid in the prevention of leptospirosis caused by Leptospira interrogans serovar Pomona, known as L. pomona. A recent study supported by Zoetis showed 75% of healthy horses have been exposed to at least one leptospiral serovar.1 As clinical signs associated with leptospirosis are non-specific, disease in horses likely occurs more frequently than is diagnosed, and exposure to Leptospira may be more prevalent than was previously understood.
Data on file, Study Report No. Restricted Grant-FTLEPTO13 (v1.0) TI-01366, Zoetis Inc.
“Until this vaccine, preventive options against leptospirosis have been limited in horses,” said Jacquelin Boggs, DVM, MS, ACVIM, senior veterinarian, Equine Technical Services at Zoetis. “Leptospirosis is a disease that can cause devastating health risks to horses and can require costly treatment. In response to the equine industry’s requests for a vaccine, Zoetis developed LEPTO EQ INNOVATOR to better equip veterinarians with the tools they need to help ensure the health and well-being of their horses.”
The addition of LEPTO EQ INNOVATOR enriches the broad portfolio of core and risk-based equine vaccines from Zoetis. LEPTO EQ INNOVATOR was shown to be clinically safe for use in foals three months of age or older and healthy pregnant mares in the second trimester.2,3 The vaccine has been field tested in more than 1,800 horses.2,3 In field safety studies with the administration of 1,808 vaccine doses, 99.8% of the horses remained reaction-free.2,3 A reaction rate of 0.002% demonstrates the vaccine’s safety.2,3
What is Equine Leptospirosis?
Equine leptospirosis is an infectious bacterial disease caused by spirochetes belonging to Leptospira species. Leptospira interrogans serovar Pomona, known as L. pomona, is the serovar most often associated with leptospirosis infections in horses in North America.4 L. pomona can colonize in the kidneys, be shed in the urine and cause horses to become septicemic.1 The bacteria is circulated in the blood and can cause uveitis, or moon blindness (the most common cause of blindness in horses), as well as abortions and kidney failure.*
Divers, TJ. Leptospirosis. In Sprayberry KA, ed. Current Therapy in Equine Medicine. 7th ed. St. Louis, MO: Saunders Elsevier, 2015:179
Horses can become infected with leptospires from standing or slow-moving water contaminated by Leptospira-infected urine, contaminated soil, bedding, feed and drinking water as well as urine from infected cattle or dogs.4,5 Common maintenance hosts — including skunks, raccoons, white-tailed deer and opossums — can become infected with L. pomona, which can be shed into shared environments and infect horses. After penetrating through mucous membranes or skin abrasions, leptospires can concentrate in the kidneys and can cause devastating clinical disease.
LEPTO EQ INNOVATOR is currently available and as with any Zoetis product, is supported by credible research and superior support. For more information please contact your Zoetis representative or visit www.LEPTOEQUINNOVATOR.COM to access a free, online Leptospirosis Risk Assessment. For each completed risk assessment, Zoetis will donate $1.00 USD, up to $1,000, to A Home for Every Horse, an organization that works with rescue horses to connect them with loving homes.
About Zoetis Zoetis (zō-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. In 2014, the company generated annual revenue of $4.8 billion. With approximately 10,000 employees worldwide at the beginning of 2015, Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in 120 countries. For more information, visit www.zoetisUS.com.
For Further Information,Contact:
Kassi HoxmeierBader Rutter262-938-5522 email@example.com
*Currently, there are no vaccines available with USDA-licensed label claims against equine abortions, uveitis or acute renal failure due to L. pomona.
1 Data on file, Study Report No. Restricted Grant-FTLEPTO13 (v1.0) TI-01366, Zoetis Inc.
2 Data on file, Study Report No. B951R-US-13-043, Zoetis Inc.
3 Data on file, Study Report No. B951R-US-13-046, Zoetis Inc.
4 Divers TJ, Chang Y-F. Leptospirosis. In: Robinson NE, Sprayberry KA, eds. Current Therapy in Equine Medicine. Vol 6. 6th ed. St. Louis, MO: Saunders Elsevier;2009:145-147.
5 Levett PN. Leptospirosis. Clin Microbiol Rev. 2001;14(2):296-326.
Mon–Fri, 8am–8pm ET
You are leaving the country website to access another site in the group.
Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.
This site is intended for U.S. Animal Healthcare Professionals.
All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2017 Zoetis Services LLC. All rights reserved.